Healthy Skepticism Library item: 10768
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: Journal Article
Williams J, Klinepeter K, Palmes G, Pulley A, Meschan Foy J.
Behavioral health practices in the midst of black box warnings and mental health reform.
Clin Pediatr (Phila) 2007 Jun; 46:(5):424-30
http://cpj.sagepub.com/cgi/reprint/46/5/424
Abstract:
A standard guide was readministered to 42 primary care pediatricians after community interventions to assess changes in their behavioral health practices. Among the outcome findings: increased screening of young children (6 months to 5 years); attention deficit hyperactivity disorder continued to be the most frequent diagnosis, with a high level of diagnostic comfort and use of stimulants; decreased comfort in the diagnosis and treatment of depression, with a significant decline in use of selective serotonin reuptake inhibitors; nearly all continued to offer nonmedication, behavioral health treatment; and a significant increase in use of social workers for community referrals. Structured interventions had limited influence on the process of change. Black box warnings exerted a powerful effect on prescribing practices. Systemic changes involving financial incentives, increased access to mental health providers, practice guidelines, and technology for continuing education may offer possibilities for changing practice patterns.
Keywords:
Publication Types:
Research Support, Non-U.S. Gov't
MeSH Terms:
Attention Deficit Disorder with Hyperactivity/diagnosis
Child
Child Behavior Disorders/diagnosis*
Child Behavior Disorders/drug therapy*
Child Behavior Disorders/epidemiology
Child, Preschool
Depressive Disorder/diagnosis
Depressive Disorder/drug therapy
Drug Labeling
Humans
Infant
Interviews
Mental Health
North Carolina/epidemiology
Pediatrics*
Physician's Practice Patterns/statistics & numerical data*
Psychotropic Drugs/therapeutic use*
Substances:
Psychotropic Drugs
